Chlorella
12 benefits mapped to clinical evidence across supplements.
Dose per serving from products
363 products in our catalogue print how much Chlorella a serving holds.
Most common: 25 mg to 50 mg and 250 mg to 500 mg, 20% of 363 products each.
| Dose per serving | Products |
|---|---|
| 25 mg or less | 12 |
| 25 mg to 50 mg | 71 |
| 50 mg to 100 mg | 49 |
| 100 mg to 250 mg | 46 |
| 250 mg to 500 mg | 71 |
| 500 mg to 1 g | 31 |
| 1 g to 2.5 g | 31 |
| 2.5 g to 5 g | 48 |
| over 5 g | 4 |
Dose per serving from research
17 study groups in 16 studies say how much Chlorella participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 g to 10 g, 29% of 17 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mg to 1 g | 2 |
| 1 g to 2.5 g | 4 |
| 2.5 g to 5 g | 3 |
| 5 g to 10 g | 5 |
| 10 g to 25 g | 2 |
| 25 g to 50 g | 1 |
Benefit Evidence
Research sources
Metabolism (3)
- Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
PubMed ID: 27475283
NAFLD RCT showed reductions in weight and fasting glucose, consistent with metabolic benefits.
- Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study
PubMed ID: 24920270
Lowered triglycerides, VLDL and non-HDL in mildly hypercholesterolemic adults.
- Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial
PubMed ID: 23234816
Reduced triglycerides and HOMA-IR in NAFLD add-on RCT implying metabolic improvements (confounded by concurrent meds).
Liver support (3)
- Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
PubMed ID: 27475283
NAFLD RCT showed weight, glucose and inflammatory marker improvements — relevant to liver health.
- Beneficial effect of Chlorella pyrenoidosa drink on healthy subjects: A randomized, placebo-controlled, double-blind, cross-over clinical trial
PubMed ID: 33755227
Decreased GOT/GPT (liver enzymes) in healthy subjects across 90-day trial.
- Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial
PubMed ID: 23234816
NAFLD randomized add‑on trial with significant reductions in ALT/AST and triglycerides — strong liver-support signal (confounded by add-on design).
Antioxidant (3)
- Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study
PubMed ID: 24920270
Increased carotenoids (antioxidant pigments) in blood concurrent with lipid improvements.
- Six-week supplementation with Chlorella has favorable impact on antioxidant status in Korean male smokers
PubMed ID: 19660910
Smokers trial showed large increases in plasma vitamin C/α‑tocopherol and antioxidant enzymes with reduced lymphocyte DNA damage.
- Beneficial effect of Chlorella pyrenoidosa drink on healthy subjects: A randomized, placebo-controlled, double-blind, cross-over clinical trial
PubMed ID: 33755227
90-day trial showed improved antioxidant enzymes (SOD, CAT), higher TEAC and reduced TBARS/8‑OHdG.
Nutrition source (2)
- Impact of Regular Intake of Microalgae on Nutrient Supply and Cardiovascular Risk Factors: Results from the NovAL Intervention Study
PubMed ID: 37049486
14-day trial showed increased 25-OH vitamin D2 and other nutrient biomarker changes—short-term nutrient changes documented.
- Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: a double-blinded, randomized, placebo-controlled study
PubMed ID: 24920270
Increased serum carotenoids (lutein/zeaxanthin, α-carotene) in mildly hypercholesterolemic adults.
Heart health (2)
- Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study
PubMed ID: 19811362
GABA-rich Chlorella reduced systolic blood pressure in borderline hypertensives in DBPC trial — meaningful cardiovascular risk factor effect.
- A dietary cholesterol challenge study to assess Chlorella supplementation in maintaining healthy lipid levels in adults: a double-blinded, randomized, placebo-controlled study
PubMed ID: 27177615
Chlorella blunted dietary-cholesterol–induced rises in total and LDL cholesterol in a randomized challenge study.
Inflammation (2)
- Effect of chlorella supplementation on systematic symptoms and serum levels of prostaglandins, inflammatory and oxidative markers in women with primary dysmenorrhea
PubMed ID: 30205315
Reduced prostaglandins (PGE2/PGF2α), hs-CRP and MDA with symptom relief in primary dysmenorrhea — clear anti-inflammatory signal.
- Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial
PubMed ID: 27475283
NAFLD trial showed decreased hs-CRP and TNF-α with improved glucose/weight — anti-inflammatory/metabolic benefit.
Mood balance (1)
- A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder
PubMed ID: 26275653
Adjunctive Chlorella extract produced clinically meaningful additional reductions in depressive and anxiety symptoms in MDD patients.
Immune support (1)
- Beneficial immunostimulatory effect of short-term Chlorella supplementation: enhancement of natural killer cell activity and early inflammatory response (randomized, double-blinded, placebo-controlled trial)
PubMed ID: 22849818
Double-blind RCT showed increased NK cell activity and Th1 cytokines — strong immunomodulatory signal.
Weight management (1)
- High-intensity interval training with or without chlorella vulgaris supplementation in obese and overweight women: effects on mitochondrial biogenesis, performance and body composition
PubMed ID: 34433510
When combined with HIIT, Chlorella produced significant fat-mass reduction vs placebo (RCT in overweight/obese women).
Cell health (1)
- Beneficial effect of Chlorella pyrenoidosa drink on healthy subjects: A randomized, placebo-controlled, double-blind, cross-over clinical trial
PubMed ID: 33755227
Decreases in TBARS and 8‑OHdG (oxidative/aging markers) indicate reduced cellular oxidative damage and potential repair.
Wellbeing (1)
- Beneficial effect of Chlorella pyrenoidosa drink on healthy subjects: A randomized, placebo-controlled, double-blind, cross-over clinical trial
PubMed ID: 33755227
Systemic improvements in antioxidant and aging markers plus lower liver enzymes suggest generalized wellness benefits.
Exercise recovery (1)
- Algae Ingestion Increases Resting and Exercised Myofibrillar Protein Synthesis Rates to a Similar Extent as Mycoprotein in Young Adults
PubMed ID: 37716611
Increased resting and post-exercise myofibrillar protein synthesis comparable to other effective protein sources — supports recovery/anabolism.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Chlorella
Search all1234 products whose verified label declares Chlorella — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.